NEA Partners 16, L.P.

10% owner at NeueHealth, Inc. · on record since Apr 10, 2024
Director at NeueHealth, Inc. · on record since Oct 6, 2025
10% owner at Regulus Therapeutics Inc. · on record since Jul 31, 2017
10% owner at ACTELIS NETWORKS INC · on record since Nov 20, 2017
10% owner at GENOCEA BIOSCIENCES, INC. · on record since Jan 23, 2018
10% owner at Marker Therapeutics, Inc. · on record since Oct 18, 2018
10% owner at Trevi Therapeutics, Inc. · on record since May 13, 2019
10% owner at Mirum Pharmaceuticals, Inc. · on record since Jul 24, 2019
10% owner at Black Diamond Therapeutics, Inc. · on record since Jan 29, 2020
10% owner at Akouos, Inc. · on record since Jun 25, 2020
10% owner at Metacrine, Inc. · on record since Sep 22, 2020
Former 10% Owner at Regulus Therapeutics Inc. · on record since Mar 16, 2021

Insider trading activity of NEA Partners 16, L.P.

Transactions on record: 18; since Feb 19, 2019

Open-market buys: 6; $36.4M

Open-market sells: 0

Companies traded: 5; last filing Feb 13, 2026

Figures computed from official regulatory filings — .

Companies where NEA Partners 16, L.P. has traded

Trevi Therapeutics, Inc.5 tx · $2.5M · Feb 13, 2026
Marker Therapeutics, Inc.2 tx · $11.8M · Dec 23, 2024
Mirum Pharmaceuticals, Inc.3 tx · Jun 15, 2023
5 tx · $10M · Sep 22, 2020
3 tx · $15M · Jun 25, 2019

Track record of NEA Partners 16, L.P.

Statistical track record

Free account

Open-market buys: 9

Last buy: Dec 23, 2024

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of NEA Partners 16, L.P.

Co-insiders of NEA Partners 16, L.P.

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Trevi Therapeutics, Inc.Listing on record	Feb 13, 2026	Other	1,851,852	1.37 USD	$2.5M		SEC
Trevi Therapeutics, Inc.Listing on record	Feb 13, 2026	OtherD (derivative)	-1,851,852	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Marker Therapeutics, Inc.Listing on record	Dec 23, 2024	Buy	554,250	3.20 USD	$1.8M	conv 43First in 12mo	SEC
Mirum Pharmaceuticals, Inc.Listing on record	Jun 15, 2023	Other	30,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Mirum Pharmaceuticals, Inc.Listing on record	Jun 15, 2023	Other	-30,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Mirum Pharmaceuticals, Inc.Listing on record	Jun 15, 2023	Other	-2,000,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Trevi Therapeutics, Inc.Listing on record	Oct 19, 2021	Buy	1,851,852	—	n/a (No price was disclosed in the filing)	conv 60Cluster	SEC
Trevi Therapeutics, Inc.Listing on record	Oct 19, 2021	BuyD (derivative)	1,851,852	—	n/a (No price was disclosed in the filing)	Cluster	SEC
Trevi Therapeutics, Inc.Listing on record	Oct 19, 2021	BuyD (derivative)	1,851,852	—	n/a (No price was disclosed in the filing)	Cluster	SEC
Marker Therapeutics, Inc.Listing on record	Mar 18, 2021	Buy	5,714,285	1.75 USD	$10M	conv 55Cluster	SEC
Metacrine, Inc.Listing unverified	Sep 22, 2020	Other	1,958,333	—	n/a (No price was disclosed in the filing)		SEC
Metacrine, Inc.Listing unverified	Sep 22, 2020	Buy	769,230	13.00 USD	$10M	conv 56ClusterFirst in 12mo	SEC
Metacrine, Inc.Listing unverified	Sep 22, 2020	OtherD (derivative)	-1,958,333	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Metacrine, Inc.Listing unverified	Sep 22, 2020	Other	332,964	—	n/a (No price was disclosed in the filing)		SEC
Metacrine, Inc.Listing unverified	Sep 22, 2020	OtherD (derivative)	-332,964	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
GENOCEA BIOSCIENCES, INC.Listing unverified	Jun 25, 2019	Buy	2,857,142	3.50 USD	$10M	conv 63Cluster	SEC
GENOCEA BIOSCIENCES, INC.Listing unverified	Feb 19, 2019	BuyD (derivative)	2,487,067	0.13 USD	$323.3K	ClusterFirst in 12mo	SEC
GENOCEA BIOSCIENCES, INC.Listing unverified	Feb 19, 2019	Buy	9,948,269	0.47 USD	$4.7M	conv 57ClusterFirst in 12mo	SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Trevi Therapeutics, Inc.Listing on record	Feb 13, 2026	Other	1,851,852	1.37 USD	$2.5M		SEC
Trevi Therapeutics, Inc.Listing on record	Feb 13, 2026	OtherD (derivative)	-1,851,852	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Marker Therapeutics, Inc.Listing on record	Dec 23, 2024	Buy	554,250	3.20 USD	$1.8M	conv 43First in 12mo	SEC
Mirum Pharmaceuticals, Inc.Listing on record	Jun 15, 2023	Other	30,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Mirum Pharmaceuticals, Inc.Listing on record	Jun 15, 2023	Other	-30,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Mirum Pharmaceuticals, Inc.Listing on record	Jun 15, 2023	Other	-2,000,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Trevi Therapeutics, Inc.Listing on record	Oct 19, 2021	Buy	1,851,852	—	n/a (No price was disclosed in the filing)	conv 60Cluster	SEC
Trevi Therapeutics, Inc.Listing on record	Oct 19, 2021	BuyD (derivative)	1,851,852	—	n/a (No price was disclosed in the filing)	Cluster	SEC
Trevi Therapeutics, Inc.Listing on record	Oct 19, 2021	BuyD (derivative)	1,851,852	—	n/a (No price was disclosed in the filing)	Cluster	SEC
Marker Therapeutics, Inc.Listing on record	Mar 18, 2021	Buy	5,714,285	1.75 USD	$10M	conv 55Cluster	SEC
Metacrine, Inc.Listing unverified	Sep 22, 2020	Other	1,958,333	—	n/a (No price was disclosed in the filing)		SEC
Metacrine, Inc.Listing unverified	Sep 22, 2020	Buy	769,230	13.00 USD	$10M	conv 56ClusterFirst in 12mo	SEC
Metacrine, Inc.Listing unverified	Sep 22, 2020	OtherD (derivative)	-1,958,333	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Metacrine, Inc.Listing unverified	Sep 22, 2020	Other	332,964	—	n/a (No price was disclosed in the filing)		SEC
Metacrine, Inc.Listing unverified	Sep 22, 2020	OtherD (derivative)	-332,964	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
GENOCEA BIOSCIENCES, INC.Listing unverified	Jun 25, 2019	Buy	2,857,142	3.50 USD	$10M	conv 63Cluster	SEC
GENOCEA BIOSCIENCES, INC.Listing unverified	Feb 19, 2019	BuyD (derivative)	2,487,067	0.13 USD	$323.3K	ClusterFirst in 12mo	SEC
GENOCEA BIOSCIENCES, INC.Listing unverified	Feb 19, 2019	Buy	9,948,269	0.47 USD	$4.7M	conv 57ClusterFirst in 12mo	SEC